The determination of lactate dynamics in brain tissue represents a challenge, partly because in vivo data at cellular resolution are not available. Here we monitored lactate in astrocytes and neurons of the primary somatosensory cortex of mice using the genetically-encoded FRET sensor Laconic in combination with two-photon laser scanning microscopy. An intravenous lactate injection rapidly increased the Laconic signal in both astrocytes and neurons, demonstrating high lactate permeability across the tissue. The signal increase was significantly smaller in astrocytes pointing to higher basal lactate levels in these cells, confirmed by a one-point in vivo calibration protocol.Trans-acceleration of the monocarboxylate transporter with pyruvate was able to reduce intracellular lactate in astrocytes but not in neurons. Collectively, this data provides in vivo evidence for a lactate gradient from astrocytes to neurons. (2016). In vivo evidence for a lactate gradient from astrocytes to neurons. Cell Metabolism, 23(1):94-102.
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Introduction
The energy demand of mammalian brain tissue is met mainly by degradation of blood borne glucose.
Classical experiments with radiolabeled substrates showed label incorporation into glutamate and glutamine in a manner suggestive of two separate tricarboxylic acid cycles, a 'large' and a 'small' compartment ( Van den Berg et al., 1969) , which were assigned to neurons and astrocytes respectively using immunohistochemical techniques (Martinez-Hernandez et al., 1977) . The concept of compartmentation in brain energy metabolism gained new momentum with the postulation of the astrocyte neuron lactate shuttle model (ANLS). In the classical version of this hypothesis, glutamate transients are linked to a cellular compartmentation of lactate (Pellerin and Magistretti, 1994) .
Glutamate released from active neurons activates astrocytic glycolysis leading to production of lactate, which serves as an energy source for neurons. Increased brain lactate levels upon neuronal activation have been observed in several studies via different techniques (Hu and Wilson, 1997; Lin et al., 2010; Prichard et al., 1991; Sappey-Marinier et al., 1992) . Also, L-lactate acts as a signaling molecule in certain mammalian brain regions (Mosienko et al., 2015; Tang et al., 2014; Yang et al., 2014) . However, the cellular origin of lactate released during increased activity (Barros and Deitmer, 2010; Stobart and Anderson, 2013) and its significance as an energy substrate or signaling molecule remains largely unclear (Barros, 2013; Weber and Barros, 2015) .
Experimental evidence from in vitro and in vivo animal studies demonstrate that lactate is able to sustain neuronal activity during glucose deprivation (Schurr, 2002; Wyss et al., 2011) and patients with non-penetrating traumatic brain injuries use peripheral lactate as brain energy substrates (for review see Glenn et al., 2015) . Furthermore, lactate transport across cell membranes via monocarboxylate transporters (MCTs) is a facilitated transport (Halestrap and Wilson, 2012) . Increased lactate production in one cell type and predominant lactate consumption in another cell type would therefore require a lactate concentration gradient from the 'producer' to the 'consumer'. Lactate dehydrogenase (LDH), located in mitochondria and the surrounding cytoplasm (Brooks et al., 1999) , links lactate to oxidative metabolism, by catalyzing the conversion between lactate and pyruvate. The higher affinity 4 for lactate of MCT and LDH isoforms expressed in neurons (MCT2 and LDH1) relative to the isoforms expressed in astrocytes (MCT1/4 and LDH5) supports an astrocytic production and neuronal consumption of lactate (Bittar et al., 1996; Debernardi et al., 2003; Laughton et al., 2000; Pierre and Pellerin, 2005) . Inhibition of astrocytic production and neuronal consumption of lactate via LDH inhibition reduces epileptic neuronal activity, possibly due to neuronal ATP depletion (Sada et al., 2015) . Moreover, the fast and transient lactate depletion in astrocytes during different in vivo and in vitro stimulation paradigms may represent the emptying of a lactate pool . Taken together, these results suggest a lactate concentration gradient from astrocytes to neurons; however, in vivo evidence of such a cellular gradient is currently absent.
Here, we investigated cell-specific lactate reservoirs in vivo employing the recently developed genetically encoded biosensor Laconic , which we specifically expressed in astrocytes and neurons. Through two-photon laser scanning microscopy (2PLSM; Denk et al., 1990) , we show, for the first time, direct indication of an in vivo lactate gradient from astrocytes to neurons.
Results

Expression of Laconic and Pyronic in vivo
To evaluate the specificity of Laconic transients, a biosensor construct specific for pyruvate ('Pyronic'; San Martín et al., 2014) was measured simultaneously with Laconic. Different adeno-associated viral (AAV) vectors, encoding either the Laconic or the Pyronic sensors, were injected in close distance to each other at the center of a craniotomy in the primary somatosensory cortex of mice ( Figure 1A , S1A).
The fluorescence of both sensors, driven by the short GFAP promoter, was located in the cytoplasm and showed the typical morphology of protoplasmic cortical astrocytes, including vascular end-feet and fine processes outlining dark non-fluorescent cells ( Figure 1B ). A similar fluorescence pattern was found throughout all imaged cortical layers, consistent with non-overlapping astrocytic domains in mice (Oberheim et al., 2009) . Human synapsin promoter constructs induced cytoplasmic fluorescence in cells matching neuronal morphology, with dark nuclei and long ranging processes toward superficial or deeper structures, located more than 150 µm below the dura ( Figure 1B ). 2PLSM was restricted to layer 2/3 cells with a laser power above 20 mW to ensure stable FRET ratios ( Figure S1F ) and below 40 mW to prevent tissue damage and bleaching of the fluorescence. Immunohistochemical staining for GFAP, CD68 and fibrinogen revealed no increase in gliosis, microglial activity or blood-brain barrier leakage (Figures S1A-D).
Insert Figure 1 about here.
Laconic sensor functions are comparable in vivo and in vitro
L-lactate binding induces a conformational change of Laconic causing a decrease in fluorescent resonance energy transfer (FRET) efficiency which increases the ratio of mTFP (monomeric teal fluorescent protein) over Venus (Figure 1A) . In vitro lactate application leads to two-site saturable
Laconic kinetics without pH sensitivity (Figure 1C and S1F, San Martín et al., 2013) . The functionality of the sensor in vivo was demonstrated with increasing doses of sodium-L-lactate injected via a tail vein 6 catheter during 2PLSM. Laconic signals in neurons and astrocytes increased non-linearly with the intravenously injected lactate dose but did not respond to 500 mM saline injections (Figure 2A , S1E).
The amplitudes of Laconic signal changes in vivo were of the same order of magnitude as in vitro cell culture, where Laconic signals can be explored at a much wider range of lactate concentrations ( Figure   2B ).
Insert Figure 2 about here.
A single intravenous injection of lactate increases Laconic signal more in neurons than in astrocytes
To compare lactate accumulation in astrocytes and neurons, Laconic was simultaneously measured in neurons and astrocytes during short intravenous L-lactate infusions over three minutes (4 mmol/kg bodyweight), elevating blood lactate levels from 0.81 ± 0.26 mM to 17 ± 5.7 mM ( Figure 3C ). The
Laconic signal increased more significantly in neurons than in astrocytes (5.7 ± 1.3% vs. 4.3 ± 1.3%, respectively; Figure 3A ) with a rise in extracellular lactate levels of 0.27 ± 0.08 mM ( Figure 3B ). This discrepancy between neurons and astrocytes could reflect higher lactate accumulation in neurons at similar baseline lactate concentrations in both cell types. Alternatively, this difference could be attributed to lower baseline lactate concentrations in neurons, which would permit a greater upward dynamic range and sensitivity of Laconic. Insert Figure 3 about here.
To distinguish between these two possibilities, the baseline lactate concentrations in astrocytes and neurons were compared by saturating Laconic in both cellular compartments. Ammonium chloride infusion over four minutes (2.5 mmol/kg bodyweight), which boosts cytosolic lactate concentration in brain cells by inhibiting mitochondrial pyruvate consumption , increased
Laconic signals in neurons and astrocytes (7.3 ± 1.3% vs. 7.4 ± 1.6%, respectively; Figure S1H ). When ammonium chloride and L-lactate were simultaneously infused intravenously beforehand, additional L-lactate application induced a significantly smaller increase of the Laconic signal in neurons (0.95 ± 0.62%, n = 53, p < 0.05, one-sample t-test) and astrocytes (0.57 ± 0.55%, n = 43 cells, p < 0.05, one-7 sample t-test) ( Figure 4A ) compared to the same lactate infusion in Figure 3 (p < 10 -7 , two-sample ttest). However, extracellular lactate levels continued to increase with additional lactate infusion by 16 ± 10.7% of the total increase (p < 0.05, one-sample t-test) ( Figure 4B ). This suggests that ammonium chloride administration increased intracellular lactate concentrations to levels which saturated Laconic. Overall, a greater change in neuronal Laconic signal was observed (∆FRET signal: 9.9 ± 2.4 %) compared to astrocytes (6.9 ± 2.0 %), supporting our hypothesis of lower baseline lactate levels in neurons ( Figure 4A ).
Insert Figure 4 about here.
Pronounced trans-acceleration in astrocytes occurs at baseline
Pyruvate application has been used in vitro to decrease intracellular lactate levels in erythrocytes (Fishbein et al., 1988) . This effect is based on a property of MCTs called trans-acceleration ( Figure 5E ),
where the presence of extracellular monocarboxylates stimulates transporter substrate efflux. This process involves a facilitated conformational switch of the substrate binding site across the cell membrane when an adequate substrate is bound ( Figure S2G , Halestrap, 2013) .
To test the capacity of intravenously applied pyruvate to produce a trans-acceleration-induced lactate efflux out of brain cells, extracellular brain lactate levels were measured with Pinnacle © biosensors ( Figure S3D ). Intravenous injection of 4 mmol/kg pyruvate over three minutes induced a transient increase of extracellular lactate levels of 0.084 ± 0.022 mM ( Figure 5B ), consistent with transacceleration of MCTs.
To compare trans-acceleration of MCTs in neurons and astrocytes, simultaneous measurements of Laconic and Pyronic during pyruvate application were performed. At baseline lactate levels, pyruvate decreased Laconic signal in astrocytes (-4.7 ± 1.5%), while signal in neurons was relatively unchanged (-0.6 ± 0.9%; Figure 5A ). Pyronic showed only minor changes. However, after achieving higher intracellular lactate concentrations by the combined infusion of ammonium chloride and lactate, pyruvate administration was able to decrease Laconic signals in both astrocytes and neurons while 8 increasing Pyronic signals in both cells ( Figure 5C ). Upon repeated i.v. injections of pyruvate, neuronal Laconic signal kept increasing, possibly due to the conversion of pyruvate to lactate (Gonzalez et al., 2005) . Under these high lactate conditions, both astrocytes and neurons show trans-acceleration ( Figure 5D ), demonstrating that neuronal MCTs are also susceptible to pyruvate-driven efflux ( Figure   5E ). In a subset of recordings this lactate accumulation was absent in neurons, in which case a lactate depletion during pyruvate infusions could not be observed.
Insert Figure 5 about here.
Discussion
The compartmentation of brain energy metabolism is a subject of intense debate, fuelled by a lack of accurate in vivo intracellular lactate measurements in different cell populations. Here, we utilized the genetically encoded lactate sensor Laconic to observe the capacity of blood borne lactate to enter both astrocytes and neurons and to approximate lactate concentrations in these cells. Whole brain tissue uptake of lactate from blood has previously been demonstrated in vivo (Cremer et al., 1979; Klein and Olsen, 1947; Wyss et al., 2011) and has been quantified in humans (Glenn et al., 2015; van Hall et al., 2009 ). We observed an accumulation of cellular and extracellular brain lactate during artificially increased blood lactate levels, which indicate a net uptake under these conditions and is in agreement with findings in humans (Boumezbeur et al., 2010; Quistorff et al., 2008; Rasmussen et al., 2011) . The ability of neurons to take up lactate is an important prerequisite for the use of lactate as an energy substrate as suggested by the ANLS (Bélanger et al., 2011; Magistretti and Allaman, 2015) , a concept that is still debated (Dienel, 2012 and references therein) . Lactate has been shown to enter oxidative energy production in physiological resting conditions (Bouzier-Sore et al., 2006) and support neuronal activity under low-glucose conditions both in vitro (Tekkök et al., 2005) and in vivo (Herzog et al., 2013; Wyss et al., 2011) .
We observed a greater neocortical Laconic signal increase in neurons than in astrocytes when blood lactate was elevated. This cell type difference was not due to altered Laconic sensitivity, as cumulative signal amplitudes were similar in both populations after decreasing intracellular lactate with pyruvate infusions and normalizing to the saturated sensor ( Figure S1I ). Therefore, baseline neuronal lactate levels could be lower where Laconic is more responsive. To evaluate this possibility, Laconic was saturated in both cellular compartments simultaneously using a mixture of lactate and ammonium (Provent et al., 2007) , which revealed a higher maximal increase of neuronal Laconic and suggests a lower baseline lactate concentration in neurons than in astrocytes ( Figure 6A ).
We utilized the trans-acceleration property of MCTs (Brown and Brooks, 1994) by applying an inward pyruvate gradient to force the cells to release their lactate. The pronounced drop of astrocytic lactate and the negligible decrease in neurons is in agreement with higher resting lactate levels in astrocytes ( Figure 6B ). We can reject the following alternative explanations for the astrocyte-specific lactate drop:
First, cell-type specific expression of isoforms in the brain has been reported with MCT1 mainly expressed in astrocytes and oligodendrocytes and MCT2 in neurons . We assessed the influence of MCT isoforms on trans-acceleration with a numerical model and demonstrated an almost linear dependency of the pyruvate-induced trans-acceleration on intracellular baseline lactate levels for both MCT1 and MCT2 ( Figure S2A -C). However, the relatively higher affinity of MCT2 than MCT1 for pyruvate in our model would predict stronger trans-acceleration of MCT2, i.e. in neurons ( Figure S2A -C). Also, trans-acceleration can be induced in cultured neurons ( Figure S2E ) and astrocytes ( Figure S2F ), where baseline lactate levels depend on the experimental conditions. The differential MCT isoform expression and kinetics can therefore not explain the predominant trans-acceleration in astrocytes.
Second, LDH diminishes lactate depletion caused by pyruvate uptake over time by transforming pyruvate into lactate. Intracellular lactate levels start to increase during pyruvate exposure if the rate of LDH-catalyzed conversion of pyruvate to lactate is high compared to lactate transport (Figure S2C) which may explain the delayed increase in lactate we observed following pyruvate infusion ( Figure 5A ).
However, the lower NADH/NAD+ ratio in neurons compared to astrocytes (Hung et al., 2011) implies weaker conversion of pyruvate to lactate and is therefore unlikely to mask pyruvate induced lactate depletion in neurons.
Third, the brain vasculature is almost entirely covered by astrocytic endfeet (Mathiisen et al., 2010; McCaslin et al., 2011) . Therefore, astrocytes are predominantly exposed to blood-borne pyruvate. The main transport limiting barrier for blood-borne pyruvate to enter brain tissue is MCT1 at the endothelial membranes and the fast diffusion within the tissue will expose all brain cells similarly (Halestrap, 2013; Miller and Oldendorf, 1986) . Accordingly, we did not observe any temporal differences between astrocytic and neuronal lactate accumulation (Figure 2A and 3A) . Additionally, buffering of lactate by Laconic is unlikely, because baseline lactate levels are higher (hundreds of µM instead of nM) and lactate transients are slower (multiple seconds instead of ms) than in the case of calcium dynamics, where buffering by the sensor is reported to be an issue (Grienberger and Konnerth, 2012) . Finally, increasing lactate levels in neurons lead to trans-acceleration and lactate efflux in neurons similarly as in astrocytes ( Figure 5C -D).
A higher resting state lactate level in astrocytes in comparison to neurons has significant implications for transcellular lactate exchange. Intracellular lactate accumulation driven by increased blood lactate and depletion during increased blood pyruvate is consistent with a facilitated transport of lactate via
MCTs. The direction of a facilitated transport is determined by the concentration gradient, for which we found evidence to be from astrocytes to neurons as has been suggested by the ANLS (Pellerin and Magistretti, 1994) ( Figure 6A ). However, alternative lactate transport mechanisms have been suggested, such as via pannexins and connexins (Barros, 2013; Giaume et al., 2013) or an unknown potassium-dependent ion channel, which would allow active lactate transport even against a chemical concentration gradient during increased neuronal activity .
In addition, astrocytic lactate could provide a small but fast energy reserve; cultured astrocytes have been shown to preferentially export glucose-derived lactate rather than lactate derived from glycogen (Sickmann et al., 2005) . Glycogen may serve as a slower energy pool, as astrocytic glycogen-derived lactate sustains neuronal function in rat optical nerve preparations for several minutes (Brown and Ransom, 2007) .
Our data provide important information about lactate concentrations of the different cellular compartments, which are fundamental for the role of lactate as an activity dependent signaling molecule (Mosienko et al., 2015) . The transport of lactate from astrocytes to neurons has been shown to be necessary for the establishment of long-term memory (Suzuki et al., 2011) by inducing the expression of plasticity-related genes (Yang et al., 2014) . Volatile halogenated anesthetics such as isoflurane are known to increase brain lactate levels (Boretius et al., 2013; Horn and Klein, 2010 ) and
Fünfschilling and colleagues (Fünfschilling et al., 2012) reported a marked decrease in tissue lactate concentration in response to the discontinuation of isoflurane anesthesia, indicative of a substantial lactate exchange. In our study, we used injectable anesthetics to avoid elevated lactate levels, but our results can be used to interpret the direction of isoflurane-induced lactate exchange at the cellular level. It is important to note, however, that Laconic did not enable us to measure cellular or whole brain lactate transport or oxidation rates in vivo, as currently available pharmacological agents (such as the MCT blocker α-cyano-4-hydroxycinnamate) are neither fast (seconds) nor specific (limited side effects) enough. Insert Figure 6 about here.
In summary, the genetically encoded lactate sensor Laconic in combination with 2PLSM was successfully applied to investigate brain energy metabolism at the single cell level in vivo for the first time. We demonstrate that neurons and astrocytes readily take up blood-borne lactate. Our data suggest a significantly lower baseline lactate level in neurons in comparison to astrocytes. Our findings furthermore support the concept of compartmentalized lactate pools with a lactate flux from astrocytes to neurons. 
Experimental
Anesthesia
The animals were anesthetized with a mixture of fentanyl ( 
Virus injection
A 4x4 mm craniotomy was performed above the somatosensory cortex using a dental drill (Bien-Air, Bienne, Switzerland) and solutions containing virus vector were injected into the primary somatosensory cortex at a close distance to achieve neighboring, but non-overlapping, sensor protein expression: 75 nL of AAV9-GFAP-Laconic (titer 3.1E12 VG/mL); 150 nL of AAV6-SYN-Laconic (titer 1.02E13 VG/mL) ; 75 nL of AAV9-GFAP-Pyronic (titer 1.6E12 VG/mL); 150 nL of AAV6-SYN-Pyronic (titer 1.15E12 VG/mL) (San Martín et al., 2014) . Large vessels were avoided to prevent bleeding and the absorption of light by hemoglobin during imaging. A square cover slip (3x3 mm, UQG Optics Ltd, UK) was placed on the exposed dura mater and fixed to the skull with dental cement, according to published protocols (Holtmaat et al., 2009 ).
Head-post implantation
A bonding agent (Gluma Comfort Bond; Heraeus Kulzer, Hanau, Germany) was applied to the cleaned skull and polymerized with a handheld blue light source (600 mW/cm 2 ; Demetron LC, Switzerland). A custom-made aluminium head post was connected with dental cement (EvoFlow; Ivoclar Vivadent AG, Liechtenstein) to the bonding agent for later reproducible animal fixation in the microscopic setup. The skin lesion was treated with antibiotic ointment (Neomycin, Cicatrex; Janssen-Cilag AG, Switzerland) and closed with acrylic glue (Histoacryl, B. Braun, Germany). After surgery the animals were kept warm and provided with analgesics (metamizole 0.2 mg/g bodyweight; Sintetica, Switzerland) and an antibiotic was added to the drinking water (enrofloxacin, 200 mg/l drinking water; Baytril, Bayer, Germany). Sensor protein expression was checked using a fluorescence stereomicroscope (Leica MZ16 FA) two to three weeks after virus injection and prior to imaging.
Intracellular lactate measurements
The mice were imaged using a custom-built two-photon laser scanning microscope (2PLSM) with a tunable pulsed laser (MaiTai eHP DS system, Spectra-Physics, CA, USA) at 870 nm wavelength and equipped with a 20x water immersion objective (W-Plan-Apochromat 20x/1.0 differential interference contrast, Zeiss, Germany). During measurements the animals were head-fixed and kept under the anesthesia described above. The galvo-mirrors and a motorized objective were used to cycle through two to four individual fields of view. Unidirectional frame scans at 0.1 Hz and 512x512 pixels resolution were acquired with ScanImage (r3.8.1; Janelia Research Campus; Pologruto et al., 2003) ). Lactate concentration in cultured cells were measured with the use of Laconic as previously described .
Extracellular lactate measurements
Extracellular lactate measurements were performed with a commercially available recording system (Pinnacle Inc., Lawrence, KS, USA). Mice were fixed in a stereotactic frame under anesthesia (isoflurane 1.5%; Abbott, North Chicago, IL, USA), the skull was opened with a dental drill, and a guide cannula (Part 7032, Pinnacle Technology, Lawrence, KS, USA) was implanted into the primary somatosensory cortex (from bregma: A/P +1.41, M/L -2.8, D/V -1.0) and fixed with dental cement to an anchor screw (Part 8209, Pinnacle Technology, Lawrence, KS, USA). After a recovery period of two weeks, the precalibrated lactate biosensor was inserted into the guide cannula (Naylor et al., 2012) . A tail vein catheter was inserted for saline, lactate and pyruvate infusions. Recording started after one hour of signal stabilization.
Blood lactate level measurements
The femoral artery was exposed and cannulated with fine bore polyethylene tubing (0.28 mm ID, 0.61 mm OD, Portex, Smith medical, UK) to measure blood lactate level. Blood drops were removed from the cannula and every fourth drop was used for an enzymatic lactate assay (Lactate Pro 2, Arkray, Japan). After each blood sample analysis, the tubing was rinsed with heparinized (50 IU/ml) 0.9% saline solution.
Intervention protocols
For intravenous interventions, a 30 Gauge needle was connected to fine bore polyethylene tubing 
Cell culture experiments
All animal procedures for the cell culture experiments were approved by the Institutional Animal Care and Use Committee of the Centro de Estudios Científicos. Mixed cortical cultures of neuronal and glial cells were prepared from 1-3 day-old neonates (C57BL/6J) as detailed previously (Bittner, 2010) . For
Laconic sensor expression, cultures were exposed to 5 x 10 6 PFU of Ad Laconic and studied after 48 h (culture day 8-10). The co-culture cells were imaged with an upright Olympus FV1000 confocal microscope and a 440 nm solid-state laser as detailed previously .
Masked ratio images were generated from background-subtracted images using ImageJ software. Figure S1H and S1I. Lactate and pyruvate are transported in and out of cells through monocarboxylate transporters (MCTs) . Competition between the two substrates for the shared binding site in the transporter and the fact that the binding site trans-locates more efficiently when complexed with a substrate leads to trans-acceleration (also known as accelerated exchange , that is the enhancement of transport of a substrate located at the opposite side of the membrane. Trans-acceleration can be explained with the following kinetic model: (A) Simulation results of intracellular lactate and pyruvate concentrations using kinetic parameters of the MCT 2 (4 µM; symmetrically distributed; pH 7.4; Koff lactate 7.6 x 10 6 s -1 and Koff pyruvate 7.6 x 10 5 s -1 ) during an extracellular 2 mM pyruvate challenge. Each line represents a different steady state lactate concentration from 0 to 1 mM at baseline. The rate of LDH is set to 10 -4 s - 
Data analysis and statistics
